Nutriband files provisional patent application for AVERSA technology

Nutriband (NTRB) announced that it has filed a provisional patent application with the U.S. Patent and Trademark Office, USPTO, to further strengthen Nutriband’s intellectual property protection for its AVERSA abuse deterrent transdermal technology. The provisional patent application covers improved aversive formulations and coating application methods to enhance the abuse deterrent properties of Nutriband’s AVERSA transdermal technology and make it even more difficult to defeat. If this provisional patent application is converted into a non-provisional patent application and a new patent is subsequently granted, it could significantly extend the patent protection for products that utilize Nutriband’s AVERSA abuse deterrent technology as the statutory patent term of a US patent is 20 years from the non-provisional filing date.